Cost-effectiveness of newborn screening for cystic fibrosis determined with real-life data
NHSEED - Economic Study or Review
Details- 2014
- van der Ploeg CP
Clinical pharmacist impact on care, length of stay, and cost in pediatric cystic fibrosis (CF) patients
NHSEED - Economic Study or Review
Details- 2013
- Cies JJ
Cost effectiveness of newborn screening for cystic fibrosis: a simulation study
NHSEED - Economic Study or Review
Details- 2013
- Nshimyumukiza L
The cost effectiveness of dry powder antibiotics for the treatment of pseudomonas aeruginosa in patients with cystic fibrosis (Provisional abstract)
NHSEED - Economic Study or Review
Details- 2013
- Tappenden P
Cost-effectiveness of carrier screening for cystic fibrosis in Australia.
NHSEED - Economic Study or Review
Details- 2012
- Norman R
Effects of a supervised, outpatient exercise and physiotherapy programme in children with cystic fibrosis
NHSEED - Economic Study or Review
Details- 2012
- Urquhart D
A decision-tree approach to cost comparison of newborn screening strategies for cystic fibrosis
NHSEED - Economic Study or Review
Details- 2012
- Wells J
Economic impact of tobramycin in patients with cystic fibrosis in a managed care population (Provisional abstract)
NHSEED - Economic Study or Review
Details- 2011
- Wertz DA
PGD for all cystic fibrosis carrier couples: novel strategy for preventive medicine and cost analysis
NHSEED - Economic Study or Review
Details- 2010
- Tur-Kaspa I
The costs of treatment of early and chronic pseudomonas aeruginosa infection in cystic fibrosis patients
NHSEED - Economic Study or Review
Details- 2009
- Braccini G